TrialScientific reports2023

Assessment of safety and intranasal neutralizing antibodies of HPMC-based human anti-SARS-CoV-2 IgG1 nasal spray in healthy volunteers.

Thanarath Imsuwansri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.